HERON THERAPEUTICS, INC. /DE/ Accrued Liabilities, Current
HERON THERAPEUTICS, INC. /DE/ (HRTX) had Accrued Liabilities, Current of $2.62 million as of 2014-03-31, per its 10-Q filed 2014-05-12.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2014-05-12
- 2014-03-31: Accrued Liabilities, Current $2.62M.
- 2013-12-31: Accrued Liabilities, Current $4.70M.
- 2013-09-30: Accrued Liabilities, Current $2.36M.
- 2013-06-30: Accrued Liabilities, Current $3.49M.
| Period end | Accrued Liabilities, Current |
|---|---|
| 2014-03-31 | $2.62M 10-Q · filed 2014-05-12 |
| 2013-12-31 | $4.70M 10-Q · filed 2014-05-12 |
| 2013-09-30 | $2.36M 10-Q · filed 2013-11-12 |
| 2013-06-30 | $3.49M 10-Q · filed 2013-08-08 |
| 2013-03-31 | $3.15M 10-Q · filed 2013-05-10 |
| 2012-12-31 | $1.75M 10-K · filed 2014-03-07 |
| 2012-09-30 | $1.03M 10-Q · filed 2012-11-05 |
| 2012-06-30 | $1.06M 10-Q · filed 2012-08-09 |
| 2012-03-31 | $1.16M 10-Q · filed 2012-05-10 |
| 2011-12-31 | $1.50M 10-K · filed 2013-03-01 |
| 2011-09-30 | $1.12M 10-Q · filed 2011-11-07 |
| 2011-06-30 | $1.98M 10-Q · filed 2011-08-08 |
| 2010-12-31 | $461.00K 10-K · filed 2012-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Lite Strategy, Inc. (LITS) | United States | $0.049B |